By Ian Walker

Barclays PLC said Friday that Chief Executive Officer C.S. Venkatakrishnan has completed treatment for non-hodgkin lymphoma and is now in remission.

Mr. Venkatakrishnan said in a letter to colleagues that he plans to work from the office over the coming weeks and to ultimately resume travel.

The FTSE 100-listed bank said in November that Mr. Venkatakrishnan had been diagnosed with non-hodgkin lymphoma, with treatment expected to last 12 to 16 weeks.

It said at the time that he would continue to actively manage the company during the treatment period.

Write to Ian Walker at ian.walker@wsj.com

(END) Dow Jones Newswires

March 03, 2023 08:25 ET (13:25 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Barclays (NYSE:BCS)
Gráfico Histórico do Ativo
De Abr 2023 até Mai 2023 Click aqui para mais gráficos Barclays.
Barclays (NYSE:BCS)
Gráfico Histórico do Ativo
De Mai 2022 até Mai 2023 Click aqui para mais gráficos Barclays.